技术领域technical field
本发明涉及医疗器件领域，尤其涉及一种医学治疗仪。The invention relates to the field of medical devices, in particular to a medical treatment instrument.
背景技术Background technique
血糖，指的是血液中所含的葡萄糖。消化后的葡萄糖由小肠进入血液，并被运输到机体中的各个细胞，是细胞的主要能量来源。正常人的血糖浓度相对稳定，落在一个可确定的血糖浓度范围之内。Blood sugar refers to the glucose contained in the blood. The digested glucose enters the blood from the small intestine and is transported to every cell in the body, which is the main energy source of the cells. The blood sugar concentration of normal people is relatively stable and falls within a determinable range of blood sugar concentration.
血糖必须保持一定的水平才能维持体内各个器官和组织的需要。血糖浓度一般在进食一到二个小时后升高，而在早餐降到最低。血糖浓度失调会导致多种疾病，持续性血糖浓度过高的高血糖和过低的低血糖都会给人们身体造成严重的影响，而由多种原因导致的持续性高血糖就会引起糖尿病，这也是血糖浓度相关的最显著的疾病。Blood sugar must maintain a certain level in order to maintain the needs of various organs and tissues in the body. Blood sugar levels generally rise one to two hours after eating and are lowest at breakfast. Disorders of blood sugar concentration can lead to various diseases. Hyperglycemia with persistent high blood sugar concentration and hypoglycemia with too low blood sugar will have a serious impact on people's health, and persistent high blood sugar caused by various reasons will cause diabetes. It is also the most significant disease related to blood glucose concentration.
现有技术中存在一些检测血糖的医疗仪器，但这些血糖仪都存在以下缺陷：(1)检测模式单一，只能检测血糖浓度；(2)检测机制落后，结构冗余度过高，精度满足不了日趋增加的精度需求；(3)没有血糖检测和胰岛素供给的控制机制，无法根据被测人体的血糖含量自适应调整被测人员的胰岛素的供给参数，例如，供给速度、供给量等，还需要人工观察血糖含量、人工决策胰岛素供给参数，自动化水平落后；(4)无线通信接口匮乏，不能将与血糖相关的各个参数及时反馈到医疗服务器端，即使存在一些简单的无线通信接口，例如蓝牙通信接口，其匹配机制和连接机制效率低下，满足不了医疗器件的高速度传输数据的要求。There are some medical instruments for detecting blood sugar in the prior art, but these blood glucose meters have the following defects: (1) the detection mode is single, and only the blood sugar concentration can be detected; (2) the detection mechanism is backward, the structure redundancy is too high, and the accuracy meets (3) There is no control mechanism for blood sugar detection and insulin supply, and it is impossible to adaptively adjust the insulin supply parameters of the measured person according to the blood sugar content of the measured human body, such as supply speed, supply amount, etc. Manual observation of blood sugar content and manual decision-making of insulin supply parameters are required, and the level of automation is lagging behind; (4) lack of wireless communication interfaces, and various parameters related to blood sugar cannot be fed back to the medical server in time, even if there are some simple wireless communication interfaces, such as Bluetooth The communication interface, its matching mechanism and connection mechanism are inefficient, and cannot meet the high-speed data transmission requirements of medical devices.
为此，本发明提出了一种医学治疗仪，能够改善落后的血糖仪的结构，将脉搏检测融入到血糖仪中，拓宽检测的生理参数的范围，提高血糖检测的精度，能够建立血糖自动控制的胰岛素供给体系，减少人工参与，另外，还能够改善现有的蓝牙通信机制，提高无线数据传输的速度和效率，从而，从整体上提高血糖仪的智能化水平。For this reason, the present invention proposes a medical treatment instrument, which can improve the structure of outdated blood glucose meters, integrate pulse detection into the blood glucose meter, broaden the range of physiological parameters detected, improve the accuracy of blood sugar detection, and establish automatic control of blood sugar In addition, it can improve the existing bluetooth communication mechanism and increase the speed and efficiency of wireless data transmission, thereby improving the intelligence level of the blood glucose meter as a whole.
发明内容Contents of the invention
为了解决现有技术存在的技术问题，本发明提供了一种医学治疗仪，将脉搏检测设备和血糖检测设备集中在一个检测仪器内同时工作，优化现有的血糖检测设备的结构，提高血糖检测的精度，同时，加入胰岛素泵和胰岛素供给控制机制，实现血糖浓度的自动控制，尤为重要的是，通过改善现有蓝牙通信接口的匹配机制和连接机制，提高血糖仪器无线连接的通信效率。In order to solve the technical problems existing in the prior art, the present invention provides a medical treatment instrument, which integrates pulse detection equipment and blood sugar detection equipment into one detection instrument to work simultaneously, optimizes the structure of existing blood sugar detection equipment, and improves blood sugar detection. At the same time, the insulin pump and insulin supply control mechanism are added to realize the automatic control of blood sugar concentration. Most importantly, the communication efficiency of wireless connection of blood glucose instruments is improved by improving the matching mechanism and connection mechanism of the existing Bluetooth communication interface.
根据本发明的一方面，提供了一种医学治疗仪，所述医学治疗仪包括胰岛素驱动设备、胰岛素泵、脉搏检测设备、血糖检测设备和飞思卡尔IMX6处理器，所述脉搏检测设备和所述血糖检测设备分别用于提取被测人员的脉搏数据和血糖数据，所述飞思卡尔IMX6处理器与所述胰岛素驱动设备、所述脉搏检测设备和所述血糖检测设备分别连接，基于所述脉搏检测设备的脉搏数据确定是否发出脉搏异常识别信号，基于所述血糖检测设备的血糖数据确定是否控制所述胰岛素驱动设备以驱动所述胰岛素泵为被测人员注射胰岛素。According to one aspect of the present invention, a medical treatment instrument is provided, the medical treatment instrument includes an insulin drive device, an insulin pump, a pulse detection device, a blood sugar detection device and a Freescale IMX6 processor, the pulse detection device and the The blood glucose detection device is respectively used to extract the pulse data and blood glucose data of the person under test, and the Freescale IMX6 processor is respectively connected with the insulin drive device, the pulse detection device and the blood glucose detection device, based on the The pulse data of the pulse detection device determines whether to send an abnormal pulse identification signal, and determines whether to control the insulin driving device to drive the insulin pump to inject insulin for the person under test based on the blood sugar data of the blood sugar detection device.
更具体地，在所述医学治疗仪中，包括：第一电阻，一端与5V电源连接，另一端与红外接收二极管的正端连接；第二电阻，一端与5V电源连接，另一端与第三电阻的一端连接；第三电阻，另一端接地，并具有与第二电阻相同的阻值；第一双路运算放大器，用于产生2.5V的基准电压，其正端与第二电阻的另一端连接，负端与第一电容的一端连接，输出端与红外发射二极管的负端连接，负端还与红外发射二极管的负端连接；第一电容，另一端接地；第四电阻，一端与红外发射二极管的负端连接；第二双路运算放大器，正端与第四电阻的另一端连接，负端与红外接收二极管的正端连接，输出端作为脉搏电压；第五电阻，并联在第二双路运算放大器负端和第二双路运算放大器输出端之间；第二电容，并联在第二双路运算放大器负端和第二双路运算放大器输出端之间；红外发射二极管，设置在被测人员耳部毛细血管位置，用于发射红外光，红外发射二极管的负端与红外接收二极管的正端连接；红外接收二极管，设置在被测人员耳部毛细血管位置，位于所述红外发射二极管的相对位置，用于接收透射被测人员耳部毛细血管后的红外光；直接数字频率合成器，用于产生频率和相位能够调整的正弦波信号以作为射频频率源用作混频使用；脉冲序列发生器，用于产生脉冲序列；混频器，与所述直接数字频率合成器和所述脉冲序列发生器分别连接，采用脉冲序列对正弦波信号进行混频调制；功率放大器，与所述混频器连接，用于将混频调制后的信号进行放大；开关电源，用作探头与功率放大器之间的接口电路，将放大后的信号加载到探头的射频收发线圈中；钕铁硼永磁型磁体结构，在容纳被测人员手指的空间内产生一个场强均匀的静态磁场；探头，放置在被测人员手指位置，缠绕射频收发线圈以将加载的信号送入所述钕铁硼永磁型磁体结构内，产生核磁共振现象，还用于将经过被测人员手指内氢质子共振后获得的衰减信号送出；飞思卡尔IMX6处理器，与所述探头连接，接收所述衰减信号，分析所述衰减信号的谱线，并计算其中葡萄糖所占比例，从而获取被测人员的血糖浓度，所述飞思卡尔IMX6处理器还与所述第二双路运算放大器的输出端连接以获得所述脉搏电压，并当所述脉搏电压在预设脉搏范围之外时，发出脉搏异常识别信号，当所述血糖浓度在预设血糖上限浓度时，发出血糖浓度过高识别信号，当所述血糖浓度在预设血糖下限浓度时，发出血糖浓度过低识别信号；胰岛素存储设备，用于预先存储预设容量的胰岛素；液位检测设备，位于所述胰岛素存储设备内，用于实时检测胰岛素存储设备内的胰岛素液位，并在胰岛素液位等于或低于预设基准液位时，发出胰岛素不足报警信号，所述液位检测设备还与所述飞思卡尔IMX6处理器连接以将所述胰岛素不足报警信号发送给所述飞思卡尔IMX6处理器；胰岛素驱动设备，与所述飞思卡尔IMX6处理器连接，当接收到所述血糖浓度过高识别信号时，根据所述飞思卡尔IMX6处理器转发的血糖浓度和所述预设血糖上限浓度的差值确定胰岛素泵驱动信号，所述胰岛素泵驱动信号决定了胰岛素泵的供应胰岛素的量值和速度；胰岛素泵，与所述胰岛素存储设备和胰岛素注射设备分别相接，与所述胰岛素驱动设备连接，用于在所述胰岛素驱动设备的控制下，将所述胰岛素存储设备内的胰岛素通过胰岛素注射设备注射到被测人员体内；胰岛素注射设备，可拆卸式埋设在被测人员体内，用于向被测人员注射胰岛素；串口通信电路，位于飞思卡尔IMX6处理器与蓝牙匹配通信设备之间，用于将所述血糖浓度和所述胰岛素不足报警信号发送到蓝牙匹配通信设备；蓝牙匹配通信设备，用于将所述血糖浓度和所述胰岛素不足报警信号无线发送到连接上的目标蓝牙设备；所述蓝牙匹配通信设备包括第一搜索子设备、第二搜索子设备和匹配连接子设备；其中，第一搜索子设备，根据蓝牙散射网中MAC地址浓度确定蓝牙MAC地址浓度最高的蓝牙微微网作为目标微微网，一个蓝牙散射网由多个蓝牙微微网组成；第二搜索子设备，与所述第一搜索子设备连接，在所述目标微微网中，寻找按信号强度排名在前的、数量不大于7的一个或多个蓝牙匹配通信设备作为一个或多个目标蓝牙设备；设备连接子设备，与所述第二搜索子设备连接，启动与所述一个或多个目标蓝牙设备的蓝牙通信连接；其中，当红外发射二极管和红外接收二极管之间无脉搏时，脉搏电压为2.5V，当红外发射二极管和红外接收二极管之间存在跳动的脉搏时，血脉使耳部透光性变差，脉搏电压大于2.5V；其中，第一双路运算放大器和第二双路运算放大器都为TI公司的双路运算放大器；其中，所述探头缠绕的射频收发线圈为鸟笼线圈、螺旋管线圈、鞍状线圈、相控阵列线圈和环状线圈中的一种；其中，直接数字频率合成器所采用的频率合成选用直接数字合成、模拟锁相环和数字锁相环中的一种；其中，当所述目标微微网中有信号的蓝牙匹配通信设备的数量为大于等于7时，所述一个或多个目标蓝牙设备的数量为7个，当所述目标微微网中有信号的蓝牙匹配通信设备的数量为小于7时，所述一个或多个目标蓝牙设备的数量为所述目标微微网中有信号的蓝牙匹配通信设备的数量。More specifically, in the medical therapeutic apparatus, it includes: a first resistor, one end is connected to the 5V power supply, and the other end is connected to the positive end of the infrared receiving diode; the second resistor is connected to the 5V power supply at one end, and the other end is connected to the third One end of the resistor is connected; the third resistor, the other end is grounded, and has the same resistance value as the second resistor; the first dual operational amplifier is used to generate a reference voltage of 2.5V, and its positive end is connected to the other end of the second resistor Connect, the negative end is connected to one end of the first capacitor, the output end is connected to the negative end of the infrared emitting diode, and the negative end is also connected to the negative end of the infrared emitting diode; the first capacitor, the other end is grounded; the fourth resistor, one end is connected to the infrared emitting diode The negative end of the emitting diode is connected; the second dual-way operational amplifier, the positive end is connected to the other end of the fourth resistor, the negative end is connected to the positive end of the infrared receiving diode, and the output end is used as a pulse voltage; the fifth resistor is connected in parallel to the second Between the negative terminal of the dual operational amplifier and the output terminal of the second dual operational amplifier; the second capacitor is connected in parallel between the negative terminal of the second dual operational amplifier and the output terminal of the second dual operational amplifier; the infrared emitting diode is arranged at The position of the ear capillary of the measured person is used to emit infrared light, and the negative end of the infrared emitting diode is connected to the positive end of the infrared receiving diode; The relative position of the diode is used to receive the infrared light transmitted through the ear capillaries of the person under test; the direct digital frequency synthesizer is used to generate a sine wave signal whose frequency and phase can be adjusted as a radio frequency source for mixing; The pulse sequence generator is used to generate the pulse sequence; the mixer is connected with the direct digital frequency synthesizer and the pulse sequence generator respectively, and adopts the pulse sequence to mix and modulate the sine wave signal; the power amplifier is connected with the The above-mentioned mixer connection is used to amplify the signal after mixing and modulation; the switching power supply is used as the interface circuit between the probe and the power amplifier, and the amplified signal is loaded into the RF transceiver coil of the probe; NdFeB The permanent magnet structure generates a static magnetic field with uniform field strength in the space containing the finger of the tested person; the probe is placed at the finger of the tested person, and the radio frequency transceiver coil is wound to send the loaded signal into the NdFeB In the permanent magnet structure, the nuclear magnetic resonance phenomenon is generated, and it is also used to send out the attenuation signal obtained after the hydrogen proton resonance in the finger of the person under test; the Freescale IMX6 processor is connected to the probe to receive the attenuation signal , analyze the spectral line of the attenuation signal, and calculate the proportion of glucose in it, so as to obtain the blood glucose concentration of the measured person, and the Freescale IMX6 processor is also connected with the output end of the second dual-way operational amplifier to Obtain the pulse voltage, and when the pulse voltage is outside the preset pulse range, send an abnormal pulse identification signal; when the blood sugar concentration is at the preset blood sugar upper limit concentration, send a blood sugar concentration identification signal When the blood glucose concentration is at the preset blood glucose lower limit concentration, an identification signal of low blood glucose concentration is sent out; the insulin storage device is used to pre-store the preset volume of insulin; the liquid level detection device , located in the insulin storage device, used for real-time detection of the insulin level in the insulin storage device, and when the insulin level is equal to or lower than the preset reference level, an insulin shortage alarm signal is sent, the liquid level detection device Also be connected with described Freescale IMX6 processor to send described insulin deficiency warning signal to described Freescale IMX6 processor; Insulin drive equipment, be connected with described Freescale IMX6 processor, when receiving described When the blood sugar concentration is too high to identify the signal, the insulin pump driving signal is determined according to the difference between the blood sugar concentration forwarded by the Freescale IMX6 processor and the preset blood sugar upper limit concentration, and the insulin pump driving signal determines the supply of the insulin pump The amount and speed of insulin; the insulin pump, which is connected to the insulin storage device and the insulin injection device respectively, is connected to the insulin driving device, and is used to transfer the insulin storage device to the insulin storage device under the control of the insulin driving device The insulin in the tester is injected into the body of the person to be tested through the insulin injection device; the insulin injection device is detachably buried in the body of the person to be tested, and is used to inject insulin to the person to be tested; the serial port communication circuit is located in the Freescale IMX6 processor and Bluetooth Between the matching communication devices, it is used to send the blood sugar concentration and the insufficient insulin alarm signal to the Bluetooth matching communication device; the Bluetooth matching communication device is used to wirelessly send the blood sugar concentration and the insulin insufficient alarm signal to the connected The target bluetooth device on the computer; the bluetooth matching communication device includes a first search sub-device, a second search sub-device and a matching connection sub-device; wherein, the first search sub-device determines the bluetooth MAC address according to the MAC address concentration in the bluetooth scatternet The bluetooth piconet with the highest concentration is used as the target piconet, and a bluetooth scatternet is composed of multiple bluetooth piconets; the second search sub-device is connected with the first search sub-device, and in the target piconet, searches for One or more bluetooth matching communication devices whose strength ranks first and whose number is not more than 7 are used as one or more target bluetooth devices; the device connects to the sub-device, connects with the second search sub-device, and starts to communicate with the one or more The Bluetooth communication connection of a target Bluetooth device; wherein, when there is no pulse between the infrared emitting diode and the infrared receiving diode, the pulse voltage is 2.5V, and when there is a beating pulse between the infrared emitting diode and the infrared receiving diode, the blood pulse makes the ear The light transmittance of the part becomes worse, and the pulse voltage is greater than 2.5V; wherein, the first dual-channel operational amplifier and the second dual-channel operational amplifier are dual-channel operational amplifiers of TI Company; wherein, the RF transceiver coil wound by the probe is a bird One of cage coils, toroidal coils, saddle coils, phased array coils, and toroidal coils; among them, the frequency synthesis used by the direct digital frequency synthesizer selects direct digital synthesis, analog phase-locked loop and digital phase-locked loop One of the above; wherein, when the number of bluetooth matching communication devices with signals in the target piconet is greater than or equal to 7, the number of the one or more target bluetooth devices is 7, when the target piconet Bluetooth matching communication with signal in When the number of devices is less than 7, the number of the one or more target Bluetooth devices is the number of Bluetooth matching communication devices with signals in the target piconet.
更具体地，在所述医学治疗仪中：所述串口通信电路为RS232串行通信接口。More specifically, in the medical therapeutic apparatus: the serial port communication circuit is an RS232 serial communication interface.
更具体地，在所述医学治疗仪中：所述飞思卡尔IMX6处理器在发出脉搏异常识别信号、血糖过高识别信号或血糖过低识别信号时，同时发出异常状态信号，否则，所述飞思卡尔IMX6处理器同时发出正常状态信号。More specifically, in the medical treatment instrument: when the Freescale IMX6 processor sends an abnormal pulse recognition signal, a high blood sugar recognition signal or a low blood sugar recognition signal, it sends an abnormal state signal at the same time, otherwise, the The Freescale IMX6 processor simultaneously signals normal status.
更具体地，在所述医学治疗仪中，所述医学治疗仪还包括：无线通信电路，与所述飞思卡尔IMX6处理器连接，用于发送异常状态信号或正常状态信号。More specifically, in the medical therapeutic apparatus, the medical therapeutic apparatus further includes: a wireless communication circuit connected with the Freescale IMX6 processor for sending abnormal state signals or normal state signals.
更具体地，在所述医学治疗仪中：所述无线通信电路为3G移动通信接口或4G移动通信接口。More specifically, in the medical therapeutic apparatus: the wireless communication circuit is a 3G mobile communication interface or a 4G mobile communication interface.
更具体地，在所述医学治疗仪中，所述医学治疗仪还包括：FLASH存储芯片，与所述飞思卡尔IMX6处理器连接，用于预先存储预设脉搏范围、预设血糖上限浓度和预设血糖下限浓度。More specifically, in the medical treatment instrument, the medical treatment instrument also includes: a FLASH memory chip connected to the Freescale IMX6 processor for pre-storing a preset pulse range, a preset blood sugar upper limit concentration and Preset blood glucose lower limit concentration.
附图说明Description of drawings
以下将结合附图对本发明的实施方案进行描述，其中：Embodiments of the present invention will be described below in conjunction with the accompanying drawings, wherein:
图1为本发明的医学治疗仪的第一实施例的结构方框图。Fig. 1 is a structural block diagram of the first embodiment of the medical therapeutic apparatus of the present invention.
附图标记：1胰岛素驱动设备；2胰岛素泵；3脉搏检测设备；4血糖检测设备；5飞思卡尔IMX6处理器Reference signs: 1 insulin driving device; 2 insulin pump; 3 pulse detection device; 4 blood sugar detection device; 5 Freescale IMX6 processor
具体实施方式detailed description
下面将参照附图对本发明的医学治疗仪的实施方案进行详细说明。Embodiments of the medical therapeutic apparatus of the present invention will be described in detail below with reference to the accompanying drawings.
血液中的糖称为血糖，绝大多数情况下都是葡萄糖。体内各组织细胞活动所需的能量大部分来自葡萄糖，所以血糖必须保持在一定水平才能维持体内各器官和组织的需求。The sugar in the blood is called blood sugar, and in most cases it is glucose. Most of the energy required for the activities of various tissue cells in the body comes from glucose, so blood sugar must be maintained at a certain level to maintain the needs of various organs and tissues in the body.
人体中的血糖的浓度通常被控制在一个很窄的范围内，血糖过高或过低都会给人们造成一定的影响。为了有效检测人体内的血糖浓度，市面上出现了多种血糖仪，尤其为患有高血压的病人所青睐。The concentration of blood sugar in the human body is usually controlled within a very narrow range, and too high or too low blood sugar will have a certain impact on people. In order to effectively detect the blood sugar concentration in the human body, a variety of blood glucose meters have appeared on the market, especially favored by patients suffering from high blood pressure.
然而，现有技术中的血糖仪检测参数单一、检测机制落后，缺乏血糖检测和胰岛素供给的自动控制机制，同时，配有的无线通信接口匹配和连接效率低下，已经满足不了医院和病人的现有要求。However, the blood glucose meter in the prior art has a single detection parameter, a backward detection mechanism, lack of an automatic control mechanism for blood glucose detection and insulin supply, and at the same time, the wireless communication interface matching and connection efficiency is low, which can no longer meet the needs of hospitals and patients. request.
为此，本发明搭建了一种医学治疗仪，将经过结构优化的高精度的脉搏监控设备和血糖监控设备集成在一个检测仪器中，同时采用血糖检测和胰岛素供给的自动控制模式以及优化后的蓝牙通信接口，为病人和医院的使用提供更多的方便。For this reason, the present invention builds a medical treatment instrument, which integrates high-precision pulse monitoring equipment and blood sugar monitoring equipment through structural optimization into one testing instrument, and adopts the automatic control mode of blood sugar testing and insulin supply and the optimized The Bluetooth communication interface provides more convenience for patients and hospitals.
图1为本发明的医学治疗仪的第一实施例的结构方框图，所述医学治疗仪包括胰岛素驱动设备、胰岛素泵、脉搏检测设备、血糖检测设备和飞思卡尔IMX6处理器，所述脉搏检测设备和所述血糖检测设备分别用于提取被测人员的脉搏数据和血糖数据，所述飞思卡尔IMX6处理器与所述胰岛素驱动设备、所述脉搏检测设备和所述血糖检测设备分别连接，基于所述脉搏检测设备的脉搏数据确定是否发出脉搏异常识别信号，基于所述血糖检测设备的血糖数据确定是否控制所述胰岛素驱动设备以驱动所述胰岛素泵为被测人员注射胰岛素。Fig. 1 is the structural block diagram of the first embodiment of the medical treatment instrument of the present invention, and described medical treatment instrument comprises insulin drive equipment, insulin pump, pulse detection equipment, blood sugar detection equipment and Freescale IMX6 processor, described pulse detection The device and the blood sugar detection device are respectively used to extract the pulse data and blood sugar data of the person being tested, and the Freescale IMX6 processor is connected to the insulin drive device, the pulse detection device and the blood sugar detection device respectively, Based on the pulse data of the pulse detection device, it is determined whether to send an abnormal pulse identification signal, and based on the blood glucose data of the blood glucose detection device, it is determined whether to control the insulin driving device to drive the insulin pump to inject insulin for the person under test.
接着，继续对本发明的医学治疗仪的第二实施例的具体结构进行进一步的说明。Next, the specific structure of the second embodiment of the medical therapeutic apparatus of the present invention will be further described.
所述医学治疗仪包括：第一电阻，一端与5V电源连接，另一端与红外接收二极管的正端连接；第二电阻，一端与5V电源连接，另一端与第三电阻的一端连接；第三电阻，另一端接地，并具有与第二电阻相同的阻值。The medical treatment instrument comprises: a first resistance, one end is connected with a 5V power supply, and the other end is connected with the positive end of an infrared receiving diode; a second resistance is connected with a 5V power supply at one end, and the other end is connected with one end of a third resistance; The other end of the resistor is grounded and has the same resistance as the second resistor.
所述医学治疗仪包括：第一双路运算放大器，用于产生2.5V的基准电压，其正端与第二电阻的另一端连接，负端与第一电容的一端连接，输出端与红外发射二极管的负端连接，负端还与红外发射二极管的负端连接；第一电容，另一端接地；第四电阻，一端与红外发射二极管的负端连接；第二双路运算放大器，正端与第四电阻的另一端连接，负端与红外接收二极管的正端连接，输出端作为脉搏电压。The medical therapeutic apparatus includes: a first dual-way operational amplifier, used to generate a reference voltage of 2.5V, its positive end is connected to the other end of the second resistor, its negative end is connected to one end of the first capacitor, and the output end is connected to the infrared emitting The negative end of the diode is connected, and the negative end is also connected to the negative end of the infrared emitting diode; the first capacitor, the other end is grounded; the fourth resistor, one end is connected to the negative end of the infrared emitting diode; the second dual-way operational amplifier, the positive end is connected to the negative end of the infrared emitting diode. The other end of the fourth resistor is connected, the negative end is connected with the positive end of the infrared receiving diode, and the output end is used as a pulse voltage.
所述医学治疗仪包括：第五电阻，并联在第二双路运算放大器负端和第二双路运算放大器输出端之间；第二电容，并联在第二双路运算放大器负端和第二双路运算放大器输出端之间；红外发射二极管，设置在被测人员耳部毛细血管位置，用于发射红外光，红外发射二极管的负端与红外接收二极管的正端连接；红外接收二极管，设置在被测人员耳部毛细血管位置，位于所述红外发射二极管的相对位置，用于接收透射被测人员耳部毛细血管后的红外光。The medical therapeutic apparatus includes: the fifth resistor, connected in parallel between the negative terminal of the second dual-way operational amplifier and the output terminal of the second dual-circuit operational amplifier; the second capacitor, connected in parallel between the negative terminal of the second dual-channel operational amplifier and the second Between the output terminals of the dual operational amplifier; the infrared emitting diode is set at the capillary position of the ear of the person under test for emitting infrared light, and the negative end of the infrared emitting diode is connected to the positive end of the infrared receiving diode; the infrared receiving diode is set At the position of capillary in the ear of the measured person, it is located at a relative position to the infrared emitting diode, and is used for receiving the infrared light transmitted through the capillary in the ear of the measured person.
所述医学治疗仪包括：直接数字频率合成器，用于产生频率和相位能够调整的正弦波信号以作为射频频率源用作混频使用；脉冲序列发生器，用于产生脉冲序列；混频器，与所述直接数字频率合成器和所述脉冲序列发生器分别连接，采用脉冲序列对正弦波信号进行混频调制；功率放大器，与所述混频器连接，用于将混频调制后的信号进行放大。The medical therapeutic apparatus includes: a direct digital frequency synthesizer, which is used to generate a sine wave signal whose frequency and phase can be adjusted to be used as a radio frequency source for mixing; a pulse sequence generator, which is used to generate a pulse sequence; a mixer , respectively connected with the direct digital frequency synthesizer and the pulse sequence generator, adopting the pulse sequence to mix and modulate the sine wave signal; the power amplifier, connected with the mixer, used to mix and modulate the sine wave signal The signal is amplified.
所述医学治疗仪包括：开关电源，用作探头与功率放大器之间的接口电路，将放大后的信号加载到探头的射频收发线圈中；钕铁硼永磁型磁体结构，在容纳被测人员手指的空间内产生一个场强均匀的静态磁场；探头，放置在被测人员手指位置，缠绕射频收发线圈以将加载的信号送入所述钕铁硼永磁型磁体结构内，产生核磁共振现象，还用于将经过被测人员手指内氢质子共振后获得的衰减信号送出。The medical treatment instrument includes: a switching power supply, used as an interface circuit between the probe and the power amplifier, and loads the amplified signal into the radio frequency transceiver coil of the probe; A static magnetic field with uniform field strength is generated in the space of the finger; the probe is placed at the finger position of the person under test, and the radio frequency transceiver coil is wound to send the loaded signal into the NdFeB permanent magnet structure to generate nuclear magnetic resonance , and is also used to send out the attenuation signal obtained after the hydrogen proton resonance in the finger of the person under test.
所述医学治疗仪包括：飞思卡尔IMX6处理器，与所述探头连接，接收所述衰减信号，分析所述衰减信号的谱线，并计算其中葡萄糖所占比例，从而获取被测人员的血糖浓度，所述飞思卡尔IMX6处理器还与所述第二双路运算放大器的输出端连接以获得所述脉搏电压，并当所述脉搏电压在预设脉搏范围之外时，发出脉搏异常识别信号，当所述血糖浓度在预设血糖上限浓度时，发出血糖浓度过高识别信号，当所述血糖浓度在预设血糖下限浓度时，发出血糖浓度过低识别信号。The medical treatment instrument includes: a Freescale IMX6 processor, connected with the probe, receiving the attenuation signal, analyzing the spectral lines of the attenuation signal, and calculating the proportion of glucose in it, so as to obtain the blood glucose of the measured person concentration, the Freescale IMX6 processor is also connected to the output of the second dual operational amplifier to obtain the pulse voltage, and when the pulse voltage is outside the preset pulse range, an abnormal pulse identification is sent signal, when the blood glucose concentration is at the preset blood glucose upper limit concentration, an identification signal of too high blood glucose concentration is issued; when the blood glucose concentration is at the preset blood glucose lower limit concentration, an identification signal of too low blood glucose concentration is issued.
所述医学治疗仪包括：胰岛素存储设备，用于预先存储预设容量的胰岛素；液位检测设备，位于所述胰岛素存储设备内，用于实时检测胰岛素存储设备内的胰岛素液位，并在胰岛素液位等于或低于预设基准液位时，发出胰岛素不足报警信号，所述液位检测设备还与所述飞思卡尔IMX6处理器连接以将所述胰岛素不足报警信号发送给所述飞思卡尔IMX6处理器。The medical treatment instrument includes: an insulin storage device, used for pre-storing insulin with a preset capacity; a liquid level detection device, located in the insulin storage device, used for real-time detection of the insulin liquid level in the insulin storage device, and When the liquid level is equal to or lower than the preset reference liquid level, an insulin insufficient alarm signal is sent, and the liquid level detection device is also connected with the Freescale IMX6 processor to send the insulin insufficient alarm signal to the Feisi Cal IMX6 processor.
所述医学治疗仪包括：胰岛素驱动设备，与所述飞思卡尔IMX6处理器连接，当接收到所述血糖浓度过高识别信号时，根据所述飞思卡尔IMX6处理器转发的血糖浓度和所述预设血糖上限浓度的差值确定胰岛素泵驱动信号，所述胰岛素泵驱动信号决定了胰岛素泵的供应胰岛素的量值和速度；胰岛素泵，与所述胰岛素存储设备和胰岛素注射设备分别相接，与所述胰岛素驱动设备连接，用于在所述胰岛素驱动设备的控制下，将所述胰岛素存储设备内的胰岛素通过胰岛素注射设备注射到被测人员体内。The medical treatment instrument includes: an insulin driving device, connected with the Freescale IMX6 processor, when receiving the identification signal of excessive blood sugar concentration, according to the blood glucose concentration forwarded by the Freescale IMX6 processor and the The difference between the preset blood sugar upper limit concentration determines the insulin pump driving signal, and the insulin pump driving signal determines the amount and speed of insulin supplied by the insulin pump; the insulin pump is connected to the insulin storage device and the insulin injection device respectively , connected with the insulin driving device, for injecting the insulin in the insulin storage device into the body of the person under test through the insulin injection device under the control of the insulin driving device.
所述医学治疗仪包括：胰岛素注射设备，可拆卸式埋设在被测人员体内，用于向被测人员注射胰岛素；串口通信电路，位于飞思卡尔IMX6处理器与蓝牙匹配通信设备之间，用于将所述血糖浓度和所述胰岛素不足报警信号发送到蓝牙匹配通信设备。The medical treatment instrument includes: insulin injection equipment, which is detachably embedded in the body of the person under test, and used to inject insulin into the person under test; a serial port communication circuit, located between the Freescale IMX6 processor and the Bluetooth matching communication device, used to For sending the blood glucose concentration and the insulin deficiency alarm signal to the bluetooth matching communication device.
所述医学治疗仪包括：蓝牙匹配通信设备，用于将所述血糖浓度和所述胰岛素不足报警信号无线发送到连接上的目标蓝牙设备；所述蓝牙匹配通信设备包括第一搜索子设备、第二搜索子设备和匹配连接子设备。The medical treatment instrument includes: a Bluetooth matching communication device, which is used to wirelessly send the blood sugar concentration and the insulin deficiency alarm signal to the connected target Bluetooth device; the Bluetooth matching communication device includes a first search sub-device, a second 2. Search for sub-devices and match-connected sub-devices.
其中，第一搜索子设备，根据蓝牙散射网中MAC地址浓度确定蓝牙MAC地址浓度最高的蓝牙微微网作为目标微微网，一个蓝牙散射网由多个蓝牙微微网组成；第二搜索子设备，与所述第一搜索子设备连接，在所述目标微微网中，寻找按信号强度排名在前的、数量不大于7的一个或多个蓝牙匹配通信设备作为一个或多个目标蓝牙设备；设备连接子设备，与所述第二搜索子设备连接，启动与所述一个或多个目标蓝牙设备的蓝牙通信连接。Wherein, the first search sub-device determines the Bluetooth piconet with the highest Bluetooth MAC address concentration as the target piconet according to the MAC address concentration in the Bluetooth scatternet, and a Bluetooth scatternet is composed of multiple Bluetooth piconets; the second search sub-device, and The first search sub-device is connected, and in the target piconet, one or more bluetooth matching communication devices ranked first by signal strength and whose number is not greater than 7 are searched as one or more target bluetooth devices; the device is connected A sub-device is connected with the second search sub-device, and initiates a Bluetooth communication connection with the one or more target Bluetooth devices.
其中，当红外发射二极管和红外接收二极管之间无脉搏时，脉搏电压为2.5V，当红外发射二极管和红外接收二极管之间存在跳动的脉搏时，血脉使耳部透光性变差，脉搏电压大于2.5V；其中，第一双路运算放大器和第二双路运算放大器都为TI公司的双路运算放大器。Among them, when there is no pulse between the infrared emitting diode and the infrared receiving diode, the pulse voltage is 2.5V. greater than 2.5V; wherein, both the first dual operational amplifier and the second dual operational amplifier are dual operational amplifiers of TI Company.
其中，所述探头缠绕的射频收发线圈为鸟笼线圈、螺旋管线圈、鞍状线圈、相控阵列线圈和环状线圈中的一种；其中，直接数字频率合成器所采用的频率合成选用直接数字合成、模拟锁相环和数字锁相环中的一种。Wherein, the RF transceiver coil wound by the probe is one of birdcage coils, toroidal coils, saddle coils, phased array coils and toroidal coils; wherein, the frequency synthesis adopted by the direct digital frequency synthesizer is directly One of digital synthesis, analog phase-locked loop, and digital phase-locked loop.
其中，当所述目标微微网中有信号的蓝牙匹配通信设备的数量为大于等于7时，所述一个或多个目标蓝牙设备的数量为7个，当所述目标微微网中有信号的蓝牙匹配通信设备的数量为小于7时，所述一个或多个目标蓝牙设备的数量为所述目标微微网中有信号的蓝牙匹配通信设备的数量。Wherein, when the number of Bluetooth matching communication devices with signals in the target piconet is greater than or equal to 7, the number of the one or more target Bluetooth devices is 7, and when the number of Bluetooth matching communication devices with signals in the target piconet When the number of matching communication devices is less than 7, the number of the one or more target Bluetooth devices is the number of Bluetooth matching communication devices with signals in the target piconet.
可选地，在所述医学治疗仪中：所述串口通信电路为RS232串行通信接口；所述飞思卡尔IMX6处理器在发出脉搏异常识别信号、血糖过高识别信号或血糖过低识别信号时，同时发出异常状态信号，否则，所述飞思卡尔IMX6处理器同时发出正常状态信号；所述医学治疗仪还包括：无线通信电路，与所述飞思卡尔IMX6处理器连接，用于发送异常状态信号或正常状态信号；所述无线通信电路为3G移动通信接口或4G移动通信接口；所述医学治疗仪还包括：FLASH存储芯片，与所述飞思卡尔IMX6处理器连接，用于预先存储预设脉搏范围、预设血糖上限浓度和预设血糖下限浓度。Optionally, in the medical therapeutic instrument: the serial port communication circuit is an RS232 serial communication interface; the Freescale IMX6 processor sends an abnormal pulse recognition signal, a high blood sugar recognition signal or a low blood sugar recognition signal When, send abnormal state signal simultaneously, otherwise, described Freescale IMX6 processor sends normal state signal simultaneously; Described medical therapy instrument also comprises: wireless communication circuit, is connected with described Freescale IMX6 processor, is used for sending Abnormal state signal or normal state signal; Described wireless communication circuit is 3G mobile communication interface or 4G mobile communication interface; Described medical therapy instrument also comprises: FLASH storage chip, is connected with described Freescale IMX6 processor, is used for advance The preset pulse range, the preset blood glucose upper limit concentration and the preset blood glucose lower limit concentration are stored.
另外，运算放大器(简称“运放”)是具有很高放大倍数的电路单元。在实际电路中，通常结合反馈网络共同组成某种功能模块。他是一种带有特殊耦合电路及反馈的放大器。其输出信号可以是输入信号加、减或微分、积分等数学运算的结果。由于早期应用于模拟计算机中，用以实现数学运算，故得名“运算放大器”。In addition, an operational amplifier ("op amp" for short) is a circuit unit with a very high amplification factor. In actual circuits, some kind of functional module is usually combined with a feedback network. He is an amplifier with a special coupling circuit and feedback. Its output signal can be the result of mathematical operations such as addition, subtraction, or differentiation and integration of the input signal. Because it was used in analog computers in the early days to realize mathematical operations, it was named "operational amplifier".
运放是一个从功能的角度命名的电路单元，可以由分立的器件实现，也可以实现在半导体芯片当中。随着半导体技术的发展，大部分的运放是以单芯片的形式存在。运放的种类繁多，广泛应用于电子行业当中。An operational amplifier is a circuit unit named from a functional point of view, which can be realized by a discrete device or in a semiconductor chip. With the development of semiconductor technology, most operational amplifiers exist in the form of a single chip. There are many types of operational amplifiers, which are widely used in the electronics industry.
采用本发明的医学治疗仪，针对现有技术中血糖仪器结构落后且无线通信功能差的技术问题，优化现有的血糖仪器的结构，加入脉搏检测设备和血糖浓度自动控制设备，同时还提高现有蓝牙通信接口的通信性能，从而提高其医疗服务的水平。Using the medical treatment instrument of the present invention, aiming at the technical problems of backward structure and poor wireless communication function of the blood sugar instrument in the prior art, the structure of the existing blood sugar instrument is optimized, pulse detection equipment and blood sugar concentration automatic control equipment are added, and the current situation is improved at the same time. It has the communication performance of the bluetooth communication interface, thereby improving the level of its medical services.
可以理解的是，虽然本发明已以较佳实施例披露如上，然而上述实施例并非用以限定本发明。对于任何熟悉本领域的技术人员而言，在不脱离本发明技术方案范围情况下，都可利用上述揭示的技术内容对本发明技术方案做出许多可能的变动和修饰，或修改为等同变化的等效实施例。因此，凡是未脱离本发明技术方案的内容，依据本发明的技术实质对以上实施例所做的任何简单修改、等同变化及修饰，均仍属于本发明技术方案保护的范围内。It can be understood that although the present invention has been disclosed above with preferred embodiments, the above embodiments are not intended to limit the present invention. For any person skilled in the art, without departing from the scope of the technical solution of the present invention, the technical content disclosed above can be used to make many possible changes and modifications to the technical solution of the present invention, or be modified into equivalent changes, etc. effective example. Therefore, any simple modifications, equivalent changes and modifications made to the above embodiments according to the technical essence of the present invention, which do not deviate from the technical solution of the present invention, still fall within the protection scope of the technical solution of the present invention.
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510997497.3ACN105455823A (en) | 2015-11-05 | 2015-11-05 | Automated blood glucose meter |
| CN201510747142.9ACN105232056B (en) | 2015-11-05 | 2015-11-05 | medical treatment instrument |
| CN201680035610.2ACN107683108A (en) | 2015-11-05 | 2016-08-19 | Automate blood glucose meter |
| PCT/CN2016/096037WO2017076103A1 (en) | 2015-11-05 | 2016-08-19 | Automated blood sugar meter |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510747142.9ACN105232056B (en) | 2015-11-05 | 2015-11-05 | medical treatment instrument |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510997497.3ADivisionCN105455823A (en) | 2015-11-05 | 2015-11-05 | Automated blood glucose meter |
| Publication Number | Publication Date |
|---|---|
| CN105232056A CN105232056A (en) | 2016-01-13 |
| CN105232056Btrue CN105232056B (en) | 2016-11-09 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510747142.9AActiveCN105232056B (en) | 2015-11-05 | 2015-11-05 | medical treatment instrument |
| CN201510997497.3APendingCN105455823A (en) | 2015-11-05 | 2015-11-05 | Automated blood glucose meter |
| CN201680035610.2APendingCN107683108A (en) | 2015-11-05 | 2016-08-19 | Automate blood glucose meter |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510997497.3APendingCN105455823A (en) | 2015-11-05 | 2015-11-05 | Automated blood glucose meter |
| CN201680035610.2APendingCN107683108A (en) | 2015-11-05 | 2016-08-19 | Automate blood glucose meter |
| Country | Link |
|---|---|
| CN (3) | CN105232056B (en) |
| WO (1) | WO2017076103A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105232056B (en)* | 2015-11-05 | 2016-11-09 | 中山标佳生物科技有限公司 | medical treatment instrument |
| CN105607530B (en)* | 2015-11-05 | 2016-12-14 | 华北理工大学 | A kind of automatization blood glucose meter |
| CN112748684B (en)* | 2020-12-21 | 2024-07-19 | 许敬梅 | Intelligent insulin pump monitoring control system and device based on RFID |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101125086A (en)* | 2006-08-18 | 2008-02-20 | 刘胜 | Closed-loop automatic controlling insulin-injecting system |
| CN102016855A (en)* | 2008-04-04 | 2011-04-13 | 海吉雅有限公司 | Device for optimizing a patient's insulin dosage regimen |
| CN103263270A (en)* | 2013-05-02 | 2013-08-28 | 卢世明 | Blood-glucose meter |
| CN204581297U (en)* | 2015-04-23 | 2015-08-26 | 何雷 | A kind of insulin resistant detector based on pulse wave |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4875486A (en)* | 1986-09-04 | 1989-10-24 | Advanced Techtronics, Inc. | Instrument and method for non-invasive in vivo testing for body fluid constituents |
| DE60040483D1 (en)* | 1999-12-28 | 2008-11-20 | Pindi Products Inc | METHOD AND DEVICE FOR NON-INVASIVE ANALYSIS OF BLOOD GLUCOSE |
| CN101107025A (en)* | 2005-01-17 | 2008-01-16 | 诺和诺德公司 | Fluid delivery device with integrated monitoring of physiological characteristics |
| WO2008037316A2 (en)* | 2006-09-28 | 2008-04-03 | Werner Regittnig | Device and method for determining a value of a physiological parameter of a body fluid |
| WO2008051939A2 (en)* | 2006-10-24 | 2008-05-02 | Medapps, Inc. | Systems and methods for medical data transmission |
| US8547239B2 (en)* | 2009-08-18 | 2013-10-01 | Cequr Sa | Methods for detecting failure states in a medicine delivery device |
| WO2012178134A2 (en)* | 2011-06-23 | 2012-12-27 | University Of Virginia Patent Foundation | Unified platform for monitoring and control of blood glucose levels in diabetic patients |
| CN202939150U (en)* | 2012-11-29 | 2013-05-15 | 南京鱼跃软件技术有限公司 | Glucometer |
| CN203564221U (en)* | 2013-10-17 | 2014-04-30 | 成都芮腾科技有限公司 | Pickup device for pulse signals |
| CN105232056B (en)* | 2015-11-05 | 2016-11-09 | 中山标佳生物科技有限公司 | medical treatment instrument |
| CN105607530B (en)* | 2015-11-05 | 2016-12-14 | 华北理工大学 | A kind of automatization blood glucose meter |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101125086A (en)* | 2006-08-18 | 2008-02-20 | 刘胜 | Closed-loop automatic controlling insulin-injecting system |
| CN102016855A (en)* | 2008-04-04 | 2011-04-13 | 海吉雅有限公司 | Device for optimizing a patient's insulin dosage regimen |
| CN103263270A (en)* | 2013-05-02 | 2013-08-28 | 卢世明 | Blood-glucose meter |
| CN204581297U (en)* | 2015-04-23 | 2015-08-26 | 何雷 | A kind of insulin resistant detector based on pulse wave |
| Title |
|---|
| 新型智能闭环胰岛素泵系统的研究;王显静;《青岛理工大学硕士学位论文》;20131231;第2页第1行至第9页第2行及图2-1* |
| 磁共振式无创血糖检测的研究;陈康;《电子科技大学硕士学位论文》;20101103;第15页第1行至第17页第4行及图3-1、3-2第15页第1行至第17页第4行及图3-1、3-2* |
| Publication number | Publication date |
|---|---|
| CN105455823A (en) | 2016-04-06 |
| WO2017076103A1 (en) | 2017-05-11 |
| CN105232056A (en) | 2016-01-13 |
| CN107683108A (en) | 2018-02-09 |
| Publication | Publication Date | Title |
|---|---|---|
| US10290208B2 (en) | Methods for enabling a disabled capability of a medical device | |
| CN105193425A (en) | Use method of noninvasive glucometer | |
| US9402956B2 (en) | Handheld diabetes manager with a user interface for displaying a status of an external medical device | |
| US20090054747A1 (en) | Method and system for providing analyte sensor tester isolation | |
| RU2682914C2 (en) | Methods for secure communication and pairing of a medical infusion device and a remote controller for such medical device | |
| US8427298B2 (en) | Method and apparatus for providing dynamic multi-stage amplification in a medical device | |
| US9049982B2 (en) | Methods to pair a medical device and at least a remote controller for such medical device | |
| CN105232056B (en) | medical treatment instrument | |
| CN106063299B (en) | Low energy wireless communication system and method for medical devices | |
| US10357180B2 (en) | Health monitoring system | |
| US20170176549A1 (en) | Use of a Measuring Appliance for Examining Constituents of a Human or Animal Body | |
| CN107949326A (en) | Non-invasive blood glucose meter | |
| US11666254B2 (en) | Interoperability validation in an analyte monitoring system | |
| CN105266811A (en) | Method for operating magnetic resonance apparatus, and magnetic resonance apparatus thereof | |
| US12379340B2 (en) | Systems, devices, and methods for RF detection of analyte sensor measurements | |
| US20140191709A1 (en) | Handheld Medical Device Simultaneous Charging And In Vivo Analyte Sampling Systems And Methods | |
| CN105607530B (en) | A kind of automatization blood glucose meter | |
| AU2019202444A1 (en) | Analyte meter with operational range configuration technique | |
| CN114746016B (en) | Methods and systems for reducing discrepancies between calculated and measured analyte levels | |
| CN105496374B (en) | Strengthen computer aided medicine system | |
| CN105561431A (en) | Insulin injection control system based on blood glucose measurement | |
| EP4335368A1 (en) | Methods and systems for reducing difference between calculated and measured analyte levels | |
| US20230000401A1 (en) | Methods and systems for reducing difference between calculated and measured analyte levels | |
| HK40077020A (en) | Methods and systems for reducing difference between calculated and measured analyte levels | |
| CN104090076A (en) | Teletransmission network blood glucose monitor |
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right | Effective date of registration:20160928 Address after:528400 Guangdong province Zhongshan Nanlang Town Ho Chung Village of Southern China city science and technology park is a modern Chinese medicine plant No. one or two layer Applicant after:Zhongshan BGH Biotechnology Co.,Ltd. Address before:18 Box 072152, Baoding, Hebei, Baoding Applicant before:Zhang Hongye | |
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right | Denomination of invention:Medical treatment equipment Effective date of registration:20231208 Granted publication date:20161109 Pledgee:Zhongshan Torch High-tech Industrial Development Zone Branch of Agricultural Bank of China Co.,Ltd. Pledgor:Zhongshan BGH Biotechnology Co.,Ltd. Registration number:Y2023980070122 |